• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Research

Scanfil extensive report: Good quality with full short-term pricing

By Antti ViljakainenHead of Research
Scanfil
Download report (PDF)

Summary

  • The target price for Scanfil has been raised to EUR 12.50 due to slightly increased long-term growth estimates, although the short-term expected return is narrowed by recent share price progress.
  • Scanfil, a global electronics contract manufacturer, benefits from a comprehensive factory network and a strong financial history, with risks primarily from the global economy and investment-driven demand.
  • The company is expected to see revenue and EBIT growth this year, driven by acquisitions and organic growth, with a projected annual revenue growth rate of 5-8% in the coming years.
  • Scanfil's valuation has risen in the short term, with current-year multiples 20-30% above its 5-year medians, making the short-term valuation challenging despite good long-term growth prospects.

This content is generated by AI. You can give feedback on it in the Inderes forum.

Translation: Original published in Finnish on 6/17/2026 at 3:15 am EEST.

We raise our target price for Scanfil to EUR 12.50 (was 11.50 €) on the heels of slightly increased long-term growth estimates. Scanfil has made good progress in recent years in executing its playbook, which relies on organic growth and acquisitions, and we expect this tactic to continue driving the company's profitable growth. Following the robust progress of the share price over the past year, the positive earnings growth projected in our forecasts has already been factored into the share. In our view, this narrows Scanfil's short-term expected return, even though the long-term story remains quite attractive.

Scanfil is a global electronics contract manufacturer

Scanfil offers its customers the opportunity to outsource the manufacture of products containing electronics and focus on their core operations, which creates flexibility in cost structures and improves capital efficiency for customers. Scanfil manufactures end products especially for the industrial, energy and environmental sectors (green transition), the healthcare segment, and the defense sector. In these customer segments, small production batches, short delivery times and long product cycles enable smaller companies to operate viably, even though competition in the industry is tight. The company has a total of 16 factories divided into the geographical areas of Central Europe, Northern Europe, APAC and the Americas. We believe that Scanfil's strengths include its comprehensive factory network, global operating model, cost-efficient culture, and extensive industry experience. The company also has a strong financial history, which reflects the viability of Scanfil's strategy over time. In our view, the clearest risks for Scanfil stem from the global economy and investment-driven demand.

Scanfil is a growth company, and the earnings growth outlook is currently good

We estimate that the relevant market volumes of Scanfil will grow faster than GDP in the long term. This growth is leveraged by the increasing outsourcing rate of industrial production, electrification, defense investments, and the relocation of certain supply chains closer to Western end-product markets. The company's market is fragmented, which gives Scanfil a good platform for inorganic growth. In the past nearly 2 years, the company has completed 3 acquisitions that expanded Scanfil’s customer base and geographic reach and established a foothold in the defense sector with strong medium-term prospects. Furthermore, despite generally sluggish market conditions in recent years, the company has managed to boost its sales, particularly among large customers, which has so far been reflected especially in strong sales figures for new projects.

We expect the company's revenue and EBIT to step up this year due to the MB and ADCO acquisitions and slight organic growth.  We estimate that revenue will grow at an annual rate of 5-8% in the coming years, driven by new projects and the positive development of underlying demand. We expect profitability (adj. /comp. EBITA %) to slowly improve with growth and rise towards the upper end of the 7-8% target range as growth scales slightly. In fact, according to our forecasts, the company's earnings are set to grow significantly by 2028.

Valuation has risen in the short term

Based on our estimates for 2026 and 2027, Scanfil's adjusted P/E ratios are 17x and 15x, while the corresponding EV/EBITA ratios are 13x and 12x. The current-year multiples, which are the main focus, are 20–30% above the company's own 5-year medians. Correspondingly, the expected annual return, consisting of earnings growth, downside in multiples (Q1’26 LTM P/E 19x), and a dividend yield of just over 2%, remains modest. Considering our DCF value, the share valuation is also somewhat tight. Scanfil is relatively undervalued by approximately 20–30% compared to global contract manufacturers and rather neutrally valued relative to Nordic peers. However, the global peer group is expensive by historical standards. Thus, we find the share's short-term valuation picture already quite challenging, even though the company has good long-term prospects, especially for growth-driven value creation.

Login required

This content is only available for logged in users

Create account

Scanfil is an international electronics contract manufacturer, specializing in industrial and B2B customers. Services include manufacturing of end products and components such as PCBs. Manufacturing services are the core of the company, supported by design, supply chain and modernization services. The company operates globally in Europe, America and Asia. Customers are primarily found in the process automation, energy efficiency, green efficiency and medical segments.

Read more on company page

Key Estimate Figures17.06.

202526e27e
Revenue797.1993.11,060.2
growth-%2.2 %24.6 %6.8 %
EBIT (adj.)56.472.680.9
EBIT-% (adj.)7.1 %7.3 %7.6 %
EPS (adj.)0.650.780.89
Dividend0.250.270.29
Dividend %2.5 %2.0 %2.2 %
P/E (adj.)15.417.115.0
EV/EBITDA8.510.09.3

Forum discussions

Antti has been a busy lead analyst and has produced an extensive report on Scanfil. Like other extensive reports, this one is available for ...
11 hours ago
by Sijoittaja-alokas
7
New PRESS release from Scanfil Scanfil is strengthening its collaboration with the AXS division of Bruker’s Life Science & Medtech business....
5/19/2026, 8:49 AM
by Sijoittaja-alokas
5
Hi, it will be available for purchase at Suomalainen Kirjakauppa, and there will also be at least three copies available for borrowing at the...
5/18/2026, 9:37 AM
by Pasi Hiedanpää
4
Hi Pasi! How will it be possible to get this 50th-anniversary work later on if one can’t make it to the fair now?
5/18/2026, 6:42 AM
by JNivala
4
You can find me and the Scanfil Group at the Tampere Investment Fair this week! Stop by our booth B37, and we’ll tell you why Scanfil Plc is...
5/18/2026, 6:32 AM
by Pasi Hiedanpää
10
Here are Nordea’s fresh thoughts on Scanfil We upgrade our fair value range for Scanfil to EUR 11.2-13.7 (10.4-12.7). Its hard work during 2024...
5/16/2026, 10:23 PM
by Sijoittaja-alokas
9
Here are Antti’s comments on the new contract landed by Scanfil. Scanfil announced on Wednesday that it has signed a cooperation agreement with...
5/15/2026, 4:54 AM
by Sijoittaja-alokas
9